UC Davis Health's IFM Fund Increases Its Commitment to Delix Therapeutics as At-Home Depression Trial Advances
November 10, 2026
November 10, 2026
DAVIS, California, Nov. 10 -- The University of California Davis campus posted the following news:
* * *
UC Davis Health's IFM Fund Increases Its Commitment to Delix Therapeutics as At-Home Depression Trial Advances
*
UC Davis Health Ventures, which is part of the Innovation and Economic Development Office, has made a follow-on investment in Delix Therapeutics through its Investing in the Future of Medicine (IFM) Fund. The investment is pa . . .
* * *
UC Davis Health's IFM Fund Increases Its Commitment to Delix Therapeutics as At-Home Depression Trial Advances
*
UC Davis Health Ventures, which is part of the Innovation and Economic Development Office, has made a follow-on investment in Delix Therapeutics through its Investing in the Future of Medicine (IFM) Fund. The investment is pa . . .